Potential New Biomarker for the Diagnosis of ALS

A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.

Related Videos
Related Content

CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease

June 1st 2023

Episode 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS

May 19th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Friday 5 — May 26, 2023

May 26th 2023

Genetic Variants Show Interactive Effects on ALS Progression and Survival Outcomes

May 26th 2023

CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease

June 1st 2023

Episode 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS

May 19th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Friday 5 — May 26, 2023

May 26th 2023

Genetic Variants Show Interactive Effects on ALS Progression and Survival Outcomes

May 26th 2023

CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease

June 1st 2023

Episode 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS

May 19th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Friday 5 — May 26, 2023

May 26th 2023

Genetic Variants Show Interactive Effects on ALS Progression and Survival Outcomes

May 26th 2023
© 2023 MJH Life Sciences

All rights reserved.